IT-hu14.18-IL2 With Radiation, Nivolumab and Ipilimumab for Melanoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Bristol-Myers Squibb
Related studies linked through entity extraction aliases.
Single and Multiple Dose Pharmacokinetics of BMS-986165 in a Randomized, Double-Blind, Placebo-Controlled Study in Healthy Chinese Subjects
- Status
- COMPLETED
- Phase
- PHASE1
An Investigational Immunotherapy Study of BMS-986301 Alone or in Combination With Nivolumab, and Ipilimumab in Participants With Advanced Solid Cancers
- Status
- COMPLETED
- Phase
- PHASE1
A Study of a Personalized Cancer Vaccine Targeting Shared Neoantigens
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study to Investigate the Effects of Itraconazole on the Pharmacokinetics of BMS-986256 in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
Cryotherapy With in Situ Immunotherapy in Melanoma Metastasis
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
An Investigational Study to Evaluate the Safety and Effectiveness of BMS-986165 With Background Treatment in Participants With Lupus Nephritis
- Status
- TERMINATED
- Phase
- PHASE2
Azacytidine During Anti-tuberculosis Therapy
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Pharmacokinetic and Metabolism of [14^C] BMS-986177 in Healthy Male Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Evaluate the Effect of Omeprazole on the Pharmacokinetics of BMS-986205 in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Efficacy of Deucravacitinib in Participants With Moderate to Severe Ulcerative Colitis
- Status
- COMPLETED
- Phase
- PHASE2
Study to Characterize the Effects of Cytochrome p450 1A2 Inhibition on Systemic Exposure to BMS-986165
- Status
- COMPLETED
- Phase
- PHASE1
Nivolumab and the Antagonistic CSF-1R Monoclonal Antibody Cabiralizumab (BMS-986227) in Patients With Relapsed/Refractory Peripheral T Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy of Nivolumab for Recurrent IDH Mutated High-Grade Gliomas
- Status
- COMPLETED
- Phase
- PHASE2
An Investigational Study to Evaluate Experimental Medication BMS-986165 in Japanese Participants With Moderate-to-Severe Psoriasis
- Status
- COMPLETED
- Phase
- PHASE3
Acute GVHD Suppression Using Costimulation Blockade to Expand Non-malignant Transplant
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Trial of Nivolumab With FOLFOX After Chemoradiation in Rectal Cancer Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Long-Term Safety and Efficacy Study of Deucravacitinib in Participants With Systemic Lupus Erythematosus
- Status
- COMPLETED
- Phase
- PHASE2
Neoadjuvant Immune Checkpoint Blockade in Resectable Malignant Pleural Mesothelioma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Phase 1/2 Trial of Gavo-cel (TC-210) in Patients With Advanced Mesothelin-Expressing Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2